Opinion: Learning from stem cell stumbles
By Jesse Reynolds,
San Diego Union Tribune
| 01. 27. 2006
The leaders of California's ambitious stem cell research program should closely read the news of the last couple months. A scandal including fraud, lies and cover-ups has ended the careers of scientists in South Korea, including Hwang Woo-suk, one of the prominent stem cell scientists in the world.
Hwang's American collaborators are now under investigation at their own universities. One of them, Jose Cibelli, sat on the committee developing research standards for California's program. Although Cibelli has voluntarily withdrawn from his activities, he did so only last week, two months into the scandal.
It is now clear that Hwang's groundbreaking announcements of the last two years were almost entirely fabricated. What's more, he obtained thousands of eggs from women in a variety of unethical and illegal ways.
Many commentators initially downplayed the relevance of the scandal, framing it as a single rotten apple in a distant foreign barrel. But that's not the case.
The stem cell research atmospheres in South Korea and America - especially California - are quite similar. There's nothing that happened there that can't happen here.
First...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...